Clinical Study on the Effect of 2% Povidone-Iodine Solution in Urethral Irrigation for Treating Male Gonorrhea

Phase 3

Recruiting

• Conditions: Urethral Irrigation; Male Gonorrhea; GonorrheaUrethritisNeisseria gonorrhoeae infection; Povidone-Iodine; Antimicrobial Therapy; Sexually Transmitted Infections (STIs); Clinical Trial

• Registration Number: TCTR20240816005
• Lead Sponsor: The First Affiliated Hospital of Gannan Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-08-16
• Last Update Posted: 19 August 2024
• Study Completion: 2024-12-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 48

Inclusion Criteria

Adult male patients diagnosed with gonorrhea through NAATs and confirmed by urethral discharge microscopy.
Age between 18 and 60 years.
Ability to provide informed consent.
No known allergies to iodine or povidone-iodine.
No concomitant sexually transmitted infections other than gonorrhea.

Exclusion Criteria

Patients aged over 60 years.
Patients with a history of allergic reactions to iodine or povidone-iodine.
Concomitant infections with Chlamydia, Mycoplasma, or other sexually transmitted infections.
Presence of urinary tract anomalies such as urethral strictures or hypospadias.
History of antibiotic treatment for gonorrhea within the last 4 weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified